Applications up, approvals slow for pot licences
OTTAWA—The number of Canadian firms applying for lucrative medical marijuana licences has topped 1,000 as a so-called “greenrush” continues to overwhelm Health Canada.
So far, only two new licences have been approved this summer even as the department tightens the application rules—and as nervous investors await decisions on their multi-million-dollar bids.
That still leaves almost 300 applications being assessed.
Some 13 licensed producers actively are providing medical marijuana to patients while another nine Health Canada-approved producers are about to market their products.
Just two new licences were issued in the last three months, raising questions among applicants about why the department’s approval process is so slow.
In July, Health Canada tightened the rules for prospective producers—increasing some security requirements to ensure inventories of medical marijuana were stored in secure facilities.
A spokesman for the department said the new restrictive rules have not affected the approval process.
“The increased security requirements have not had an impact on the processing of active applications,” Gary Scott Holub said in an e-mail.
Even so, some applicants say the move appears to be aimed at smaller players to discourage them from applying.
And some still-unapproved firms are under pressure from their impatient investors, who have leased buildings, hired staff, and paid legal fees with no returns in sight.
“Everybody is just living in fear” of having their applications rejected,” said one insider.
Health Canada radically changed the rules for medical marijuana on April 1 to end home-grown weed production in favour of commercial products under a new licensing system.
The department expects the new regime will create a private industry eventually worth some $1.3 billion in sales annually, with perhaps half-a-million customers.
Some applicants want to position themselves in the medical-marijuana market for the day when recreational cannabis may become legal.